Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2A study of GSK3772701 in adults with uncomplicated Plasmodium falciparum malaria
PACTR202508592564689Phase 2Not yet recruiting
- Sponsor
- GSK
- Start
- Feb 2026
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 2 trial of MMV367 in Malaria, sponsored by GSK. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
MMV367
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202508592564689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202508592564689.